A drug with the SMILES CC1CCN(C2=NN3C(=N)/C(=C\c4ccc(OC(=O)c5ccco5)cc4)C(=O)N=C3S2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 9.227\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC1CCN(C2=NN3C(=N)/C(=C\c4ccc(OC(=O)c5ccco5)cc4)C(=O)N=C3S2)CC1
CC1CCN(C2=NN3C(=N)/C(=C\c4ccc(OC(=O)c5ccco5)cc4)C(=O)N=C3S2)CC1
[4-[(E)-[5-imino-2-(4-methylpiperidin-1-yl)-7-oxo-[1,3,4]thiadiazolo[3,2-a]pyrimidin-6-ylidene]methyl]phenyl] furan-2-carboxylate